Publications (original articles or review articles) published in 2017 from OUS - Department of Urology
12 publications found
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
BMC Urol, 17 (1), 111
DOI 10.1186/s12894-017-0302-7, PubMed 29197360
Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
Int J Oncol, 51 (1), 223-234
DOI 10.3892/ijo.2017.4017, PubMed 28560383
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346, PubMed 28972967
Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
Curr Opin Urol, 27 (2), 107-111
DOI 10.1097/MOU.0000000000000368, PubMed 27906777
The role of nutraceuticals and phytotherapy in the management of urinary tract infections: What we need to know?
Arch Ital Urol Androl, 89 (1), 1-6
DOI 10.4081/aiua.2017.1.1, PubMed 28403585
Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium
J Alzheimers Dis, 55 (1), 371-379
DOI 10.3233/JAD-160461, PubMed 27662296
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells
Tumour Biol, 39 (8), 1010428317713671
DOI 10.1177/1010428317713671, PubMed 28789597
Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells
Oncotarget, 8 (28), 46363-46380
DOI 10.18632/oncotarget.18199, PubMed 28624784
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Sci Rep, 7 (1), 5081
DOI 10.1038/s41598-017-05086-6, PubMed 28698547
A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
Rev Urol, 19 (4), 213-220
DOI 10.3909/riu0780, PubMed 29472825
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
Eur Urol, 72 (4), 509-518
DOI 10.1016/j.eururo.2017.03.027, PubMed 28408174
Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
Urology, 110, 140-147
DOI 10.1016/j.urology.2017.07.048, PubMed 28823634